Price
Financials
Standalone, Rs crore| Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 13.42 | 13.74 | 8.57 | 7.17 | 8.51 | 11.03 | 10.81 | 13.51 |
| Operating costs | 8.84 | 8.49 | 4.70 | 8.49 | 8.10 | 9.89 | 9.48 | 12.49 |
| EBITDA | 4.58 | 5.25 | 3.87 | -1.32 | 0.41 | 1.14 | 1.33 | 1.02 |
| EBITDA margin % | 34.13% | 38.21% | 45.16% | -18.41% | 4.82% | 10.34% | 12.30% | 7.55% |
| Depreciation & amortisation | 0.34 | 0.34 | 0.38 | 0.43 | 0.47 | 0.45 | 0.51 | 0.46 |
| Finance costs | 0.25 | 0.65 | 0.59 | 0.66 | 0.37 | 0.51 | 0.57 | 0.80 |
| Non-operating income | 0.03 | 0.00 | 0.24 | 0.61 | 0.76 | 0.56 | 0.44 | 0.52 |
| Pre-tax profit | 4.02 | 4.26 | 3.14 | -1.80 | 0.33 | 0.74 | 0.69 | 0.28 |
| Effective tax rate % | 27.61% | 29.34% | 27.39% | -22.22% | 6.06% | 55.41% | 26.09% | 28.57% |
| Profit after tax | 2.90 | 3.01 | 2.29 | -1.41 | 0.31 | 0.33 | 0.51 | 0.20 |
| Earnings per share (Rs) | 5.37 | 1.86 | 1.01 | -0.62 | 0.14 | 0.15 | 0.23 | 0.09 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Revenue from operations | 4.13 | 15.49 | 20.26 | 23.74 | 14.84 | 19.17 | 22.53 |
| Operating costs | 3.46 | 10.20 | 12.75 | 13.91 | 12.29 | 17.62 | 20.13 |
| EBITDA | 0.67 | 5.29 | 7.51 | 9.83 | 2.55 | 1.55 | 2.40 |
| EBITDA margin % | 16.22% | 34.15% | 37.07% | 41.41% | 17.18% | 8.09% | 10.65% |
| Depreciation & amortisation | 0.36 | 0.39 | 0.43 | 0.69 | 0.81 | 0.92 | 0.97 |
| Finance costs | 0.50 | 0.44 | 0.24 | 0.90 | 1.25 | 0.88 | 1.38 |
| Non-operating income | 0.01 | 0.00 | 0.00 | 0.03 | 0.85 | 1.32 | 0.93 |
| Pre-tax profit | -0.18 | 4.46 | 6.84 | 8.27 | 1.34 | 1.07 | 0.98 |
| Effective tax rate % | 50.00% | 7.40% | 26.02% | 28.66% | 34.33% | 40.19% | 26.53% |
| Profit after tax | -0.27 | 4.12 | 5.05 | 5.91 | 0.88 | 0.64 | 0.71 |
| Earnings per share (Rs) | -2.00 | 30.52 | 37.41 | 3.65 | 0.39 | 0.28 | 0.31 |
| Paid out as dividend % | 0.00% | 0.00% | 0.00% | 0.00% | 12.84% | 0.00% | 0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Revenue CAGR | % | 8% | -2% | 18% | ||
| Profit CAGR | % | -29% | -50% | 13% | ||
| Share price CAGR | % | % | -23% | -1% | ||
| Average return on equity | % | 9% | 2% | 1% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Net block (property, plant) | 8.02 | 8.21 | 10.87 | 11.17 | 18.18 | 18.00 | 29.46 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.53 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current & other assets | 1.31 | 1.59 | 6.61 | 19.84 | 39.50 | 45.25 | 46.66 |
| Total assets | 9.33 | 9.80 | 17.48 | 31.01 | 57.68 | 63.25 | 76.65 |
| Share capital | 1.35 | 1.35 | 1.35 | 8.10 | 11.30 | 11.30 | 11.30 |
| Reserves & surplus | -2.28 | 1.84 | 6.92 | 6.08 | 38.18 | 38.82 | 39.53 |
| Total debt | 8.76 | 4.33 | 5.18 | 11.69 | 5.47 | 10.06 | 21.03 |
| Other liabilities & provisions | 1.50 | 2.28 | 4.03 | 5.14 | 2.73 | 3.07 | 4.79 |
| Equity + liabilities | 9.33 | 9.80 | 17.48 | 31.01 | 57.68 | 63.25 | 76.65 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -0.54 | 6.11 | 9.55 | 5.33 | -8.01 | 3.34 | 7.07 |
| Investing cash flow | -0.18 | -0.71 | -3.37 | -1.42 | -7.82 | -0.69 | -12.38 |
| Free cash flow (after capex) | -0.72 | 5.54 | 6.45 | 4.35 | -15.83 | 2.60 | -5.32 |
| Financing cash flow | 0.67 | -4.87 | -6.55 | -3.78 | 26.32 | -1.29 | 4.85 |
| Net change in cash | -0.05 | 0.53 | -0.37 | 0.14 | 10.49 | 1.35 | -0.47 |
| Cash conversion (OCF / EBITDA) % | -81% | 120% | 104% | 32% | -327% | 215% | 295% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Return on capital employed % | 63.84% | 67.53% | 46.64% | 6.41% | 3.39% | 3.60% | |
| Receivable days | 86.61 | 13.43 | 91.88 | 274.13 | 507.16 | 468.01 | 397.56 |
| Inventory days | 64.68 | 18.38 | |||||
| Payable days | 494.37 | 148.80 | |||||
| Cash cycle (days) | -343.07 | -116.99 | 91.88 | 274.13 | 507.16 | 468.01 | 397.56 |
| Working capital days | -166.15 | -46.18 | -28.10 | 79.18 | 554.63 | 426.69 | 305.71 |
| Jun 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Promoter group % | 63.72% | 63.72% | 63.72% | 63.72% | 63.74% | 63.74% | 63.76% | 64.33% |
| Retail & others % | 36.27% | 36.28% | 36.28% | 36.28% | 36.26% | 36.26% | 36.24% | 35.67% |
| Shareholder count | 2,511 | 1,772 | 1,537 | 1,522 | 1,409 | 1,389 | 1,350 | 1,288 |
Fundamentals
Market value₹ 46.2 Cr.
Last price₹ 20.4
P/E (trailing)64.2
Book value / share₹ 22.5
Return on capital3.60 %
Return on equity1.43 %
Dividend yield0.00 %
Face value₹ 5.00
Revenue CAGR (TTM)18%
Profit CAGR (TTM)13%
Standalone figures.
Valuation
Market capRs 32 Cr
Enterprise valueRs 44 Cr
P/E (TTM)5.48x
Price to book2.28x
Price to sales1.36x
EV / EBITDA4.44x
EV / EBIT4.77x
EV / sales1.84x
Price to cash flow6.08x
Earnings yield18.24%
Profitability
Operating margin (excl. other income)41.41%
Operating margin (incl. other income)41.53%
EBITDA margin41.53%
Pre-tax margin34.84%
Net profit margin24.89%
ROE52.65%
ROCE46.64%
ROA24.38%
ROE, 3-year average168.46%
ROCE, 3-year average59.34%
ROA, 3-year average34.82%
ROIC (approx.)25.61%
Tax rate28.66%
Other income / net worth0.21%
Growth
Sales growth (latest year)17.18%
Profit growth (latest year)17.03%
Sales CAGR, 3 years79.13%
Per share
EPS (TTM)Rs 3.65
EPS (latest year)Rs 3.65
EPS, 3-year averageRs 23.86
Book value per shareRs 8.75
Sales per shareRs 14.65
Cash flow per shareRs 3.29
Efficiency
Asset turnover0.77x
Fixed asset turnover2.13x
Inventory turnover6.62x
Inventory days55 days
Debtor days274 days
Debtors turnover1.33x
Leverage
Total debtRs 12 Cr
Cash and bankRs 0 Cr
Net debtRs 11 Cr
Debt to equity0.82x
Net debt / EBITDA1.15x
Interest coverage10.19x
Owners' fund to total sources45.73%
Debt to assets37.70%
Cash flow
Operating cash flow (latest year)Rs 5 Cr
Investing cash flow (latest year)Rs -1 Cr
Financing cash flow (latest year)Rs -4 Cr
Net change in cash (latest year)Rs 0 Cr
Sales to cash flow4.45x
Statement figures
Net sales (TTM)Rs 24 Cr
Net sales (latest year)Rs 24 Cr
Operating profit excl. other income (latest year)Rs 10 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs 10 Cr
PBDT (TTM)Rs 9 Cr
Profit before tax (TTM)Rs 8 Cr
Tax (latest year)Rs 2 Cr
Net profit (TTM)Rs 6 Cr
Net profit (latest year)Rs 6 Cr
Depreciation (TTM)Rs 1 Cr
Interest (TTM)Rs 1 Cr
Cost of goods sold (latest year)Rs 3 Cr
Total expenditure (latest year)Rs 14 Cr
Total income (latest year)Rs 24 Cr
Share capitalRs 8 Cr
ReservesRs 6 Cr
Shareholders' fundsRs 14 Cr
Total assetsRs 31 Cr
Net blockRs 11 Cr
ReceivablesRs 18 Cr
InventoryRs 0 Cr
Other liabilitiesRs 5 Cr
Shares outstanding (crore)1.62
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 5.5 is at the 11th percentile of its own 2.3-year range
(median 6.6, low 5.0, high 10.7).
P/B 2.28 is at the 11th percentile (median 4.06).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | AATMAJ | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | +3.9% | -2.8% | +6.7 pts |
| 1 month | +10.5% | -6.8% | +17.3 pts |
| 3 months | -0.7% | -7.6% | +6.9 pts |
| 6 months | -19.7% | +0.4% | -20.1 pts |
| 1 year | +1.0% | -9.9% | +10.9 pts |
| 2 years | -48.3% | -13.6% | -34.8 pts |
| 3 years | -56.0% | +14.2% | -70.2 pts |
Red flags
F-score 3 of 8| explain | Receivables outrunning sales Receivables grew 250% vs sales +17% in 2026 |
| explain | Share dilution Share count up 1057% in a year, 1057% in three |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Mar 2026Sales ₹14 Cr +88.4% vs Mar 2024.
Net profit ₹0 Cr +114.2%.
Against our estimate for Mar 2026: sales -12.8%, profit -61.1% in line.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Apollo Hospitals Enterprise Ltd | 124,503 | 59.2 | 17.4 % |
| Manipal Health Enterprises Ltd | 98,357 | 111 | 12.1 % |
| Max Healthcare Institute Ltd | 95,589 | 63.8 | 14.7 % |
| Aster DM Quality Care Ltd | 63,976 | 177 | 11.6 % |
| Fortis Healthcare Ltd | 62,058 | 58.2 | 13.4 % |
| Global Health Ltd | 38,048 | 66.4 | 17.4 % |
| Narayana Hrudayalaya Ltd | 36,579 | 42.4 | 15.5 % |
| Krishna Institute of Medical Sciences Ltd | 32,336 | 155 | 9.50 % |
| Dr Agarwals Health Care Ltd | 15,701 | 106 | 10.9 % |
| Rainbow Childrens Medicare Ltd | 13,892 | 48.5 | 17.4 % |
| Park Medi World Ltd | 11,898 | 42.8 | 19.5 % |
| Yatharth Hospital & Trauma Care Services Ltd | 10,676 | 58.9 | 12.9 % |
| Healthcare Global Enterprises Ltd | 10,505 | 218 | 8.30 % |
| Jupiter Life Line Hospitals Ltd | 8,591 | 44.9 | 14.8 % |
| Kovai Medical Center & Hospital Ltd | 6,579 | 25.7 | 22.6 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Less than 100 unique PAN traded in previous 30 daysMandatory Market making period in SME scrip is overSME scrip is not regularly tradedScrip PE is greater than 50 (4 trailing quarters)
Quick answers
What is the market cap of Aatmaj Healthcare Ltd?
Aatmaj Healthcare Ltd (AATMAJ) has a market capitalisation of Rs 46.2 Cr. at the 2026-09-30 close.
What is the P/E ratio of Aatmaj Healthcare Ltd?
Aatmaj Healthcare Ltd trades at a P/E of 64.2 on trailing twelve-month profit, at the 2026-09-30 close.
What were Aatmaj Healthcare Ltd's latest quarterly results?
In the Mar 2026 quarter, Aatmaj Healthcare Ltd sales was Rs 14 Cr (+88.4% vs Mar 2024) and net profit was Rs 0 Cr.
What is the 52-week high and low of Aatmaj Healthcare Ltd?
The 52-week high is Rs 25.50 and the 52-week low is Rs 16.70.